Inhaled dye for lung malformations in children
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 months and 14 years old.
- A CT or MRI scan must have shown a congenital lung malformation (a lung issue present from birth).
- Your child should not have any other life-threatening health problems.
- Your child must not have a severe lung infection right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special fluorescent dye called indocyanine green (ICG) can help surgeons see better during laparoscopic Heller-Dor surgery for achalasia. It may improve the safety and success of the procedure.
This study tests a tiny amount of a dye called Indocyanine Green (ICG) during surgery to see if it safely shows blood flow to the gut and urinary organs. It may help doctors check that these organs are getting enough blood during the operation.
This study tests a dye called ICG that makes cancer cells glow under a special camera. Doctors use it during surgery to find and remove lung tumors that have spread from another cancer.
This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.
This study compares two ways doctors find the exact border between lung segments during a minimally invasive surgery. You'll receive either a safe dye (ICG) or a carbon dioxide gas method to help the surgeon see clearly, which may make surgery more precise.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
Hear when a new Indocyanine Green trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.